MIMs and its partners are building PandemIA - an explainable AI platform to personalize COVID-19 vancination and treatment. PandemIA monitors genomic, clinical and geodynamic data and delivers real-time indicators to public health organizations. These indicators will allow indentification of the groups most at risk of developing deadly forms on COVID-19.

MIMs

Montreal

MIMs startup from Montreal, Canada is ranked 1575 out of 2449 worldwide and 80 from the 124 startups in Canada. See more information and additional rankings on the StartupBlink Global Ecosystem Map